- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 1, 2026 | 13.59M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 13.67M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 13.77M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 14.1M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 14.15M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $12.6M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $11.02M |
| Short Term Investments | Q2 2026 · Mar 31, 2026 | $81.67M |
| Short Term Investments | Q2 2026 · Sep 30, 2025 | $84.48M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $9.4M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $21.49M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $242.81M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $249.65M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $256.16M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $265.9M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $267.44M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $275.76M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $12.69M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $36.6M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $20.74M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $50.01M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $163M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $198.49M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $263.55M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $306.17M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.04 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.09 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.04 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.09 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | −$0.04 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $13.23M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $26.44M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $12.28M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $23M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$528K |
| Net Income | Q2 2026 · Mar 31, 2026 | −$1.14M |
| Net Income | Q2 2026 · Mar 31, 2025 | $1.33M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$579K |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$2.07M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$3.89M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $1.68M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | −$364K |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $11.16M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $22.55M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $13.96M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $22.64M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $23.23M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $46.18M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $26.66M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $47.68M |
| Revenue | Q2 2026 · Mar 31, 2026 | $34.39M |
| Revenue | Q2 2026 · Mar 31, 2026 | $68.73M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $40.62M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $70.32M |